Mavacamten: Read Past the Trial Status
ODYSSEY-HCM offers a useful exercise in keeping a stopping reason, endpoint results and unanswered questions in their proper places.
THE HIVEPROSPECT WEEKLY
Drug discoveries, difficult failures and the business decisions between them.
Filed under Hypertrophic cardiomyopathy · Clear filter
ODYSSEY-HCM offers a useful exercise in keeping a stopping reason, endpoint results and unanswered questions in their proper places.